Clemens Rohrl
Overview
Explore the profile of Clemens Rohrl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
524
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haider L, Blank-Landeshammer B, Reiter N, Heckmann M, Iken M, Weghuber J, et al.
J Nutr Biochem
. 2025 Feb;
139:109868.
PMID: 39984059
Numerous dietary phytochemicals such as curcumin, lutein and isoflavones are associated with health beneficial activities, however their application is often limited by their low bioavailability. Therefore, bioenhancers represent a feasible...
2.
Steinbauer S, Wallner M, Karl L, Gramatte T, Essl K, Iken M, et al.
Nutrients
. 2025 Jan;
17(2).
PMID: 39861489
Individuals with special metabolic demands are at risk of deficiencies in fat-soluble vitamins, which can be counteracted via supplementation. Here, we tested the ability of micellization alone or in combination...
3.
Blank-Landeshammer B, Schwarzinger B, Arnaut V, Gramatte T, Drotarova I, Feichtinger M, et al.
Food Chem
. 2024 Apr;
451:139419.
PMID: 38677134
Plant extracts rich in phytochemicals are known for their health benefits. Plant extract library from edible plants obtained from the region of Upper Austria was prepared. Food grade extraction procedures...
4.
Heckmann M, Stadlbauer V, Drotarova I, Gramatte T, Feichtinger M, Arnaut V, et al.
Antioxidants (Basel)
. 2024 Mar;
13(3).
PMID: 38539831
Numerous underexplored plant species are believed to possess considerable potential in combating oxidative stress and its associated health impacts, emphasizing the need for a comprehensive methodological screening approach to assess...
5.
Steinbauer S, Konig A, Neuhauser C, Schwarzinger B, Stangl H, Iken M, et al.
Sci Rep
. 2024 Feb;
14(1):3547.
PMID: 38347122
Cholesterol deposition in intimal macrophages leads to foam cell formation and atherosclerosis. Reverse cholesterol transport (RCT), initiated by efflux of excess cholesterol from foam cells, counteracts atherosclerosis. However, targeting RCT...
6.
Oberle R, Kuhrer K, Osterreicher T, Weber F, Steinbauer S, Udonta F, et al.
Life Sci Alliance
. 2022 May;
5(9).
PMID: 35577388
Despite enormous efforts to improve therapeutic options, pancreatic cancer remains a fatal disease and is expected to become the second leading cause of cancer-related deaths in the next decade. Previous...
7.
Ollinger N, Neuhauser C, Schwarzinger B, Wallner M, Schwarzinger C, Blank-Landeshammer B, et al.
Mol Nutr Food Res
. 2022 Apr;
66(12):e2101133.
PMID: 35426970
Scope: Sea buckthorn (Hippophaes rhamnoides) is capable of ameliorating disturbed glucose metabolism in animal models and human subjects. Here, the effect of sea buckthorn oil as well as of extracts...
8.
Rohrl C, Steinbauer S, Bauer R, Roitinger E, Otteneder K, Wallner M, et al.
Food Funct
. 2021 Oct;
12(21):10432-10442.
PMID: 34617546
Decreasing circulating low-density lipoprotein (LDL) cholesterol levels leads to decreased risk of cardiovascular diseases. Natural compounds are capable of lowering LDL-cholesterol even on top of lifestyle modification or medication. To...
9.
Bowers M, Liang T, Gonzalez-Bohorquez D, Zocher S, Jaeger B, Kovacs W, et al.
Cell Stem Cell
. 2020 May;
27(1):98-109.e11.
PMID: 32386572
Altered neural stem/progenitor cell (NSPC) activity and neurodevelopmental defects are linked to intellectual disability. However, it remains unclear whether altered metabolism, a key regulator of NSPC activity, disrupts human neurogenesis...
10.
Englinger B, Laemmerer A, Moser P, Kallus S, Rohrl C, Pirker C, et al.
Int J Cancer
. 2020 Feb;
147(6):1680-1693.
PMID: 32064608
Ponatinib is a small molecule multi-tyrosine kinase inhibitor clinically approved for anticancer therapy. Molecular mechanisms by which cancer cells develop resistance against ponatinib are currently poorly understood. Likewise, intracellular drug...